Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis

Relationship Between Adherence to Antihypertensive Medication Regimen and Out-of-Pocket Costs Among People Aged 35 to 64 With Employer-Sponsored Health Insurance

(2019) Madeleine M. Baker-Goering et al.   Preventing Chronic Disease

Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France

(2019) M. Hiligsmann et al.   OSTEOPOROSIS INTERNATIONAL

Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review

(2019) F Fatoye et al.   BMJ Open

Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2019) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Do out-of-pocket costs affect medication adherence in adults with rheumatoid arthritis? A systematic review

(2018) Parvaneh Heidari et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women

(2018) Akeem A. Yusuf et al.   Archives of Osteoporosis

Effect of Medication Copayment on Adherence and Discontinuation in Medicare Beneficiaries with Type 2 Diabetes: A Retrospective Administrative Claims Database Analysis

(2018) Manjiri D. Pawaskar et al.   Diabetes Therapy

Risk of subsequent fracture after prior fracture among older women

(2018) A. Balasubramanian et al.   OSTEOPOROSIS INTERNATIONAL

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates

(2017) A. Diez-Perez et al.   OSTEOPOROSIS INTERNATIONAL

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

(2016) Robert A Adler et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Second fractures among older adults in the year following hip, shoulder, or wrist fracture

(2016) J. P. W. Bynum et al.   OSTEOPOROSIS INTERNATIONAL

Impact of Patient Reimbursement Timing and Patient Out-of-Pocket Expenses on Medication Adherence in Patients Covered by Private Drug Insurance Plans

(2016) François Després et al.   Journal of Managed Care & Specialty Pharmacy

Adherence to oral bisphosphonates: 30 more minutes in dosing instructions matter

(2015) M. Vytrisalova et al.   CLIMACTERIC

The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine

(2014) Nicole C Wright et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men

(2013) Patrick Haentjens   ANNALS OF INTERNAL MEDICINE

Eliminating the need for fasting with oral administration of bisphosphonates

(2013) Michael Pazianas et al.   Therapeutics and Clinical Risk Management

Osteoporosis in the European Union: a compendium of country-specific reports

(2013) A. Svedbom et al.   Archives of Osteoporosis

Osteoporosis in the European Union: medical management, epidemiology and economic burden

(2013) E. Hernlund et al.   Archives of Osteoporosis

Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years

(2012) M. R. McClung et al.   OSTEOPOROSIS INTERNATIONAL

Osteoporotic Fractures

(2011) Sangeeta Budhia et al.   PHARMACOECONOMICS

Impact of a Prescription Copayment Increase on Lipid-Lowering Medication Adherence in Veterans

(2009) Jalpa A. Doshi et al.   CIRCULATION

Excess mortality following hip fracture: a systematic epidemiological review

(2009) B. Abrahamsen et al.   OSTEOPOROSIS INTERNATIONAL

Fracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates

(2008) Arlene M Gallagher et al.   JOURNAL OF BONE AND MINERAL RESEARCH